---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-018637"
form_type: "8-K"
ticker: "SONM"
cik: "0001178697"
company_name: "DNA X, Inc."
filed_at: "2025-10-20T23:59:59+00:00"
generated_at: "2026-05-17T03:11:30.988911+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Sonim appoints Executive Chairman, approves 1-for-18 reverse split; Nasdaq extension to Dec 31

## Summary
- Michael Mulica appointed Executive Chairman effective Oct 16, 2025; receives $300k salary, $250k annual RSU grant, and $500k RSU award tied to asset purchase with Social Mobile.
- Stockholders approved reverse stock split at 1-for-18 ratio, effective Oct 27, 2025, to regain compliance with Nasdaq minimum bid price.
- Stockholders also approved increase in authorized shares from 100M to 1B; did not approve 1M share increase in equity incentive plan.
- Nasdaq granted extension until Dec 31, 2025 to regain compliance with stockholders' equity minimum of $2.5M; company submitted compliance plan.
- Reverse Stock Split will not issue fractional shares; cash in lieu will be paid.

## SEC filing metadata
- accession: 0001493152-25-018637
- form_type: 8-K
- ticker: SONM
- cik: 0001178697
- company_name: DNA X, Inc.
- filed_at: 2025-10-20T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01, 5.02, 5.03, 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1178697/000149315225018637/0001493152-25-018637-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1178697/000149315225018637/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-018637
- JSON: https://secwatch.observer/filing/0001493152-25-018637.json
- Plain text: https://secwatch.observer/filing/0001493152-25-018637.txt

## Source-grounded claims
- claim_id: 9d6493e3e31d8fdfbd56d42b66b6c2a59bb996cb
  claim: DNA X, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).
  evidence_excerpt: October 17, 2025, the Company received written notification from Nasdaq (the “Extension Notice”) granting the Company an extension through December 31, 2025, to regain compliance with Nasdaq Listing Rule 5550(b)(1). Under the terms of the extension, on or before December 31, 2025, the Company must evidence compliance with Nasdaq Listing Rule 5550(b)(1) as set forth in the Extension Notice. The Company intends to satisfy these requirements within the current extension period or, if necessary, to request a further extension from Nasdaq, which would be subject to Nasdaq’s discretion. The Company
  evidence_url: https://www.sec.gov/Archives/edgar/data/1178697/000149315225018637/0001493152-25-018637-index.htm
- claim_id: c2fa72be72473cc8e73022d899f51ec267723e8d
  claim: DNA X, Inc. received a nasdaq extension granted notice regarding stockholders equity (rules 5550(b)(1)).
  evidence_excerpt: October 17, 2025, the Company received written notification from Nasdaq (the “Extension Notice”) granting the Company an extension through December 31, 2025, to regain compliance with Nasdaq Listing Rule 5550(b)(1). Under the terms of the extension, on or before December 31, 2025, the Company must evidence compliance with Nasdaq Listing Rule 5550(b)(1) as set forth in the Extension Notice. The Company intends to satisfy these requirements within the current extension period or, if necessary, to request a further extension from Nasdaq, which would be subject to Nasdaq’s discretion. The Company
  evidence_url: https://www.sec.gov/Archives/edgar/data/1178697/000149315225018637/0001493152-25-018637-index.htm
- claim_id: 2186ab068fdc032002b49acc55357c2545578071
  claim: DNA X, Inc.: Amendment to increase authorized shares from 100,000,000 to 1,000,000,000 (effective 2025-10-16).
  evidence_excerpt: On October 16, 2025, the Company effected the Authorized Share Proposal by filing a certificate of amendment to the Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware, effective as of such date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1178697/000149315225018637/0001493152-25-018637-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.